Biocon informs about press release

13 May 2024 Evaluate

Biocon has informed that it enclosed the press release titled ‘Biocon Limited signs semi-exclusive distribution and supply deal for the commercialization of generic Saxenda® (Liraglutide) in Mexico with Medix.’ The above information will also be available on the website of the Company at www.biocon.com.

The above information is a part of company’s filings submitted to BSE.

Biocon Share Price

374.85 7.50 (2.04%)
24-Mar-2026 09:09 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1791.50
Dr. Reddys Lab 1274.20
Cipla 1234.00
Zydus Lifesciences 887.75
Lupin 2320.80
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×